MOH
- Marketing authorisation holder: ASCENDIS PHARMA BONE
- Status: likely_approved
🇮🇱 Yorvipath in Israel
Yorvipath (PALOPEGTERIPARATIDE) regulatory status in Israel.
Marketing authorisation
Yorvipath in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Nephrology approved in Israel
Frequently asked questions
Is Yorvipath approved in Israel?
Yes. MOH has authorised it.
Who is the marketing authorisation holder for Yorvipath in Israel?
ASCENDIS PHARMA BONE holds the Israeli marketing authorisation.